These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 601775)
1. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension. Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775 [TBL] [Abstract][Full Text] [Related]
2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system. Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244 [TBL] [Abstract][Full Text] [Related]
3. Effect of chronic and acute changes in sodium balance on the urinary excretion of prostaglandins E2 and F2 alpha in normal man. Rathaus M; Podjarny E; Weiss E; Ravid M; Bauminger S; Bernheim J Clin Sci (Lond); 1981 Apr; 60(4):405-10. PubMed ID: 7018797 [TBL] [Abstract][Full Text] [Related]
4. Implication of renal prostaglandin E in urinary sodium excretion. Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774 [TBL] [Abstract][Full Text] [Related]
5. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients. Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018 [TBL] [Abstract][Full Text] [Related]
6. Effect of chronic and acute changes in sodium balance on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension. Rathaus M; Korzets Z; Bernheim J Nephron; 1982; 31(4):337-42. PubMed ID: 6960266 [TBL] [Abstract][Full Text] [Related]
7. Urinary prostaglandin and sodium metabolism in patients with essential hypertension. Yasujima N; Abe K; Irokawa N; Chiba S; Sato M; Seino M; Sakurai Y; Saito K; Ito T; Ritsu K; Yoshinaga K Tohoku J Exp Med; 1978 Mar; 124(3):277-83. PubMed ID: 635902 [TBL] [Abstract][Full Text] [Related]
8. Suppression of plasma renin activity by indomethacin in man. Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675 [TBL] [Abstract][Full Text] [Related]
9. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants. Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087 [TBL] [Abstract][Full Text] [Related]
10. Effect of sodium restriction and angiotensin II infusion in Bartter's syndrome. Sann L; David M; Richard P; Floret D; Sassard J; Bizollon CA; Francois R Pediatr Res; 1976 Dec; 10(12):971-7. PubMed ID: 995500 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824 [TBL] [Abstract][Full Text] [Related]
12. Sar1-Ile8-angiotensin II decreases urinary PGE2 and PGF2alpha excretion in rabbits on dietary sodium restriction. Stahl RA; Attallah AA Eur J Pharmacol; 1980 Jul; 65(1):81-4. PubMed ID: 7398779 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition by des-1-Asp-8-lle-angiotensin ii of the steroidogenic response to restricted sodium intake in the rat. Sarstedt CA; Vaughan ED; Peach MJ Circ Res; 1975 Sep; 37(3):350-8. PubMed ID: 1157223 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins. Diz DI; Baer PG; Nasjletti A J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977 [TBL] [Abstract][Full Text] [Related]
15. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems. Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807 [TBL] [Abstract][Full Text] [Related]
16. Is low urinary prostaglandin concentration a stage in the development of essential hypertension? Papanicolaou N; Safar M; Tsapara-Stavroulaki A; Baskiotis C; Lefkos N; Paris M; Marketos S; Bariéty J; Dontas A; Milliez P Prostaglandins Med; 1979 Jul; 3(1):53-67. PubMed ID: 399528 [TBL] [Abstract][Full Text] [Related]
17. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man. Speckart P; Zia P; Zipser R; Horton R J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512 [TBL] [Abstract][Full Text] [Related]
18. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension. Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352 [TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension. Favre L; Jornot L; Riondel A; Vallotton M Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481 [TBL] [Abstract][Full Text] [Related]
20. Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension. Stahl RA; Jonassen AJ; Paravicini M; Schollmeyer P Klin Wochenschr; 1982 Jun; 60(11):579-81. PubMed ID: 7050523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]